MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway

Oncogene

Volumn 34, Issue 13, 2015, Pages 1698-1708

  MacHa, M A ^a   Rachagani, S ^a   Pai, P ^a   Gupta, S ^a   Lydiatt, W M ^b   Smith, R B ^b   Johansson, S L ^a   Lele, S M ^a   Kakar, S S ^c   Lee, J H ^d   Meza, J ^b   Ganti, A K ^a   Jain, M ^a,b   Batra, S K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c University of Louisville School of Medicine   (United States)

^d SANFORD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; MUC4 PROTEIN, HUMAN; MUCIN 4; P16 PROTEIN, HUMAN; RETINOBLASTOMA PROTEIN; TUMOR PROTEIN;

ANIMAL; CELL AGING; CELL CYCLE CHECKPOINT; CELL MOTION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; HEAD AND NECK TUMOR; HUMAN; MOUSE; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL AGING; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYCLIN E; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MUCIN-4; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RETINOBLASTOMA PROTEIN;

EID: 84898501515     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.102     Document Type: Article

References (56)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008; 371: 1695-1709.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
3. Gil Z, Fliss DM. Contemporary management of head and neck cancers. Isr Med Assoc J 2009; 11: 296-300.
4. Kaur S, Kumar S, Momi N, Sasson AR, Batra SK. Mucins in pancreatic cancer and its microenvironment. Nat Rev Gastroenterol Hepatol 2013; 10: 607-620.
5. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009; 9: 874-885.
6. Chakraborty S, Jain M, Sasson AR, Batra SK. MUC4 as a diagnostic marker in cancer. Expert Opin Med Diagn 2008; 2: 891-910.
7. Bafna S, Singh AP, Moniaux N, Eudy JD, Meza JL, Batra SK. MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. Cancer Res 2008; 68: 9231-9238.
8. Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL et al. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res 2007; 5: 309-320.
9. Ponnusamy MP, Batra SK. Ovarian cancer: emerging concept on cancer stem cells. J Ovarian Res 2008; 1: 4-1.
10. Rachagani S, Macha MA, Ponnusamy MP, Haridas D, Kaur S, Jain M et al. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis 2012; 33: 1953-1964.
11. Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G et al. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin Cancer Res 2011; 17: 6658-6670.
12. Tang AL, Hauff SJ, Owen JH, Graham MP, Czerwinski MJ, Park JJ et al. UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck 2012; 34: 1480-1491.
13. Campisi J, d'Adda di FF. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-740.
14. Mukhopadhyay P, Lakshmanan I, Ponnusamy MP, Chakraborty S, Jain M, Pai P et al. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. PLoS ONE 2013; 8: e54455.
15. Cammarano MS, Nekrasova T, Noel B, Minden A. Pak4 induces premature senescence via a pathway requiring p16INK4/p19ARF and mitogen-activated protein kinase signaling. Mol Cell Biol 2005; 25: 9532-9542.
16. Zhang X, Kim J, Ruthazer R, McDevitt MA, Wazer DE, Paulson KE et al. The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Mol Cell Biol 2006; 26: 8252-8266.
17. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513-522.
18. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113: 703-716.
19. Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, Medrano EE. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res 2002; 62: 6231-6239.
20. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000; 2: E65-E67.
21. Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 1995; 19: 12146-12150.
22. Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. FASEB J 2008; 22: 966-981.
23. Dey P, Rachagani S, Chakraborty S, Singh PK, Zhao X, Gurumurthy CB et al. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clin Cancer Res 2012; 18: 6188-6198.
24. Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 2005; 18: 1295-1304.
25. Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M et al. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol 2005; 29: 806-813.
26. Rabassa ME, Croce MV, Pereyra A, Segal-Eiras A. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis. BMC Cancer 2006; 6: 253.
27. Weed DT, Gomez-Fernandez C, Bonfante E, Lee TD, Pacheco J, Carvajal ME et al. MUC4 (sialomucin complex) expression in salivary gland tumors and squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001; 124: 127-141.
28. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007; 67: 7713-7722.
29. Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y et al. MUC4: a novel prognostic factor of oral squamous cell carcinoma. Int J Cancer 2012; 130: 1768-1776.
30. Kitazono I, Higashi M, Kitamoto S, Yokoyama S, Horinouchi M, Osako M et al. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas. Pancreas 2013; 42: 1120-1128.
31. Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M et al. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. PLoS ONE 2012; 7: e49251.
32. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342-348.
33. Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P et al. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 2010; 29: 5741-5754.
34. Dimri GP, Campisi J. Molecular and cell biology of replicative senescence. Cold Spring Harb Symp Quant Biol 1994; 59: 67-73.
35. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432: 307-315.
36. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-2492.
37. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. New Engl J Med 2001; 345: 1890-1900.
38. Liggett WH Jr., Sewell DA, Rocco J, Ahrendt SA, Koch W, Sidransky D. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res 1996; 56: 4119-4123.
39. Cai Y, Liu YF, Li SL, Pan YX, Zhu Y, Yu YN. [Cyclin E overexpression and centrosome amplification in squamous cell carcinoma of oral cavity]. Zhonghua Bing Li Xue Za Zhi 2007; 36: 375-378.
40. Peeper DS, Shvarts A, Brummelkamp T, Douma S, Koh EY, Daley GQ et al. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat Cell Biol 2002; 4: 148-153.
41. Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res 2004; 64: 622-630.
42. Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S et al. Pathobiological implications of MUC4 in non-small-cell lung cancer. J Thorac Oncol 2013; 8: 398-407.
43. Urnov FD, Wolffe AP. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 2001; 20: 2991-3006.
44. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406: 593-599.
45. Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ et al. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS ONE 2009; 4: e4687.
46. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998; 391: 597-601.
47. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA 1998; 95: 10493-10498.
48. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006; 119: 2620-2623.
49. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 20: 261-269.
50. Nichols AC, Chan-Seng-Yue M, Yoo J, Xu W, Dhaliwal S, Basmaji J et al. A pilot study comparing HPV-positive and HPV-negative head and neck squamous cell carcinomas by whole exome sequencing. ISRN Oncol 2012; 2012: 809370.
51. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333: 1157-1160.
52. Lleonart ME, Artero-Castro A, Kondoh H. Senescence induction; a possible cancer therapy. Mol Cancer 2009; 8: 3.
53. Moniaux N, Varshney GC, Chauhan SC, Copin MC, Jain M, Wittel UA et al. Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans. J Histochem Cytochem 2004; 52: 253-261.
54. Macha MA, Rachagani S, Gupta S, Pai P, Ponnusamy MP, Batra SK et al. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Lett ; 341: 166-177.
55. Ponnusamy MP, Singh AP, Jain M, Chakraborty S, Moniaux N, Batra SK. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br J Cancer 2008; 99: 520-526.
56. Chung IS, Son YI, Ko YJ, Baek CH, Cho JK, Jeong HS. Peritumor injections of purified tumstatin delay tumor growth and lymphatic metastasis in an orthotopic oral squamous cell carcinoma model. Oral Oncol 2008; 44: 1118-1126.